Comment from The Geneva Foundation, HHS-OPHS-2018-0021, HHS-OPHS-2018-0021-0001, N/A
The Geneva FoundationOtherIndividual
Summary: The commenter is providing a clinical trial informed consent form for a study on abemaciclib for prostate cancer. This is a submission of a document rather than a comment expressing a position on the proposed federal action.
CYCLONE 3: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Abemaciclib in Combination with Abiraterone plus Prednisone in Men with High-Risk Metastatic Hormone-Sensitive Prostate Cancer - DDEAMC